2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
12
Carcinoma, Non-Small-Cell Lung
6
Carcinoma, Hepatocellular
5
Breast Neoplasms
5
Lung Neoplasms
4
Glioblastoma
4
Neoplasms
3
Myelodysplastic Syndromes
3
Squamous Cell Carcinoma of Head and Neck
2
Mycosis Fungoides
2
Mouth Neoplasms
2
Lymphoma, T-Cell
2
Lymphoma, Large-Cell, Anaplastic
2
Liver Neoplasms
2
Leukemia, Myeloid, Acute
2
Gliosarcoma
2
Waldenstrom Macroglobulinemia
1
Urinary Bladder Neoplasms
1
Thrombosis
1
Radiation Injuries
1
Prostatic Neoplasms, Castration-Resistant
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Neurofibrosarcoma
1
Neurofibromatosis 1
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
Multiple Myeloma
1
Mesothelioma, Malignant
1
Meningioma
1
Interventions
enzalutamide
20
Abiraterone Acetate
11
Prednisone
7
Docetaxel
7
radium Ra 223 dichloride
6
darolutamide
5
abiraterone
5
apalutamide
3
olaparib
2
niraparib
2
cabazitaxel
2
atezolizumab
2
Pluvicto
2
Nivolumab
2
zimberelimab
1
xentuzumab
1
tasquinimod
1
sacituzumab govitecan
1
sabizabulin
1
quemliclustat
1
pembrolizumab
1
ipatasertib
1
ibrutinib
1
gedatolisib
1
gallium 68 PSMA-11
1
fludrocortisone acetate
1
TVB-2640
1
Standard of Care
1
Rosuvastatin Calcium
1
Radium-223
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Prostatic Neoplasms, Castration-Resistant
×
Photons
×
Clear all
NCT04141709
2023-02-08
OLI-CR-P
Technische Universität Dresden
Phase NA
Unknown
66 enrolled